Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells

Despite the benefits associated with radiotherapy and chemotherapy for glioblastoma (GBM) treatment, most patients experience a relapse following initial therapy. Recurrent or progressive GBM usually does not respond anymore to standard therapy, and this is associated with poor patient outcome. GBM...

Descripción completa

Detalles Bibliográficos
Autores principales: Affinito, Alessandra, Quintavalle, Cristina, Esposito, Carla Lucia, Roscigno, Giuseppina, Giordano, Catello, Nuzzo, Silvia, Ricci-Vitiani, Lucia, Scognamiglio, Iolanda, Minic, Zoran, Pallini, Roberto, Berezovski, Maxim V., de Francisis, Vittorio, Condorelli, Gerolama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068199/
https://www.ncbi.nlm.nih.gov/pubmed/32169805
http://dx.doi.org/10.1016/j.omtn.2020.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068199/
https://www.ncbi.nlm.nih.gov/pubmed/32169805
http://dx.doi.org/10.1016/j.omtn.2020.02.005

Ejemplares similares